Clinical Trials Sponsored by Jonathan A. Bernstein, MD

Total 5 results

Jonathan A. Bernstein, MD

Completed

Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody

Chronic Idiopathic Urticaria

United States
Jonathan A. Bernstein, MD

Completed

The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment

Eczema | Atopic Dermatitis

United States
Bernstein, Jonathan A., M.D.
Dyax Corp.

Unknown

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (ACE)

Angioedema

United States
Bernstein, Jonathan A., M.D.
Merck Sharp & Dohme LLC

Unknown

Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)

Rhinitis

United States
Gerstein, Hertzel, MD
Wyeth is now a wholly owned subsidiary of Pfizer; GlaxoSmithKline; Canadian Institutes... and other collaborators

Completed

The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Glucose Metabolism Disorders | Cardiovascular Disease | Impaired Glucose Tolerance

3

Subscribe